Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.
暂无分享，去创建一个
B. Clotet | J. Martinez-Picado | C. Brander | Felipe García | M. Plana | J. Gatell | J. Benito | A. León | J. Blanco | J. Carrillo | M. Muñoz-Fernández | M. Esteban | J. García-Arriaza | B. Perdiguero | J. Alcamí | J. Peña | B. Mothe | N. Rallón | C. E. Gómez | J. L. Jiménez | N. González | S. Sánchez-Palomino | N. Climent | J. Pich | M. Puertas | J. C. López Bernaldo de Quirós | A. Guardo | J. Arnaiz | C. Álvarez-Fernández | M. Rosás | Nuria González